Prasugrel, a Platelet P2Y₁₂ Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 4, 2016-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y 12 antagonist both in-vitro and ex-vivo in human volunteers

By Fox S.C.  

Platelets, Vol. 24, Iss. 5, 2013-08 ,pp. : 392-400

Informa Healthcare

Access to resources Recommend Favorite

P2Y12 receptor in platelet activation

By Kim Soochong   Kunapuli Satya P.  

Platelets, Vol. 22, Iss. 1, 2011-02 ,pp. : 54-58

Informa Healthcare

Access to resources Recommend Favorite

The relative importance of the ADP receptors, P2Y 12 and P2Y 1 , in thrombin-induced platelet activation

By Nylander S.   Mattsson C.   Ramstrom S.   Lindahl T.L.  

Thrombosis Research, Vol. 111, Iss. 1, 2003-01 ,pp. : 65-73

Elsevier

Access to resources Recommend Favorite

Effects of P2Y₁ and P2Y₁₂ receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets

By Mateos-Trigos G.   Evans R.J.   Heath M.F.  

Platelets, Vol. 13, Iss. 5-6, 2002-08 ,pp. : 285-292

Informa Healthcare

Access to resources Recommend Favorite